Top news of the week: 30.10.2023.
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
A pioneering gene therapy aims to free patients of blood disease. Is a cure at hand?
After years of blood transfusions, “they think getting cured is totally normal,” said Alissa Finlayson.
Biotech Firm Cargo Preps IPO Launchpad
October 26, 2023 Investors seeking a new pharmaceutical play for their portfolio have a new initial public offering (IPO) to consider.
Late to the game, Mass. drugmakers seek to piggyback on obesity drug boom
Several biotechs in Massachusetts are seeking to elbow their way into the lucrative market, which is dominated by Denmark’s Novo Nordisk and Eli Lilly.
Evaluation of a novel lyophilized-pellet-based 2019-nCoV nucleic acid detection kit for the diagnosis of COVID-19
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept the world and poses a serious threat to human health. In the ...
New Report Highlights Pharma Commercial Model Requires An Urgent Overhaul
While many manufacturers are adapting, new research reveals resistance and challenges as they navigate the "new normal."
31 cities, regions selected as federal tech hubs for AI and biotechnology
They’re part of a program designed to invest in high-potential U.S. regions and make them globally competitive in emerging technologies.
Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals